Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing. Vlessis Katherine et al. JNCI cancer spectrum 2020 Feb 4(1) pkz095

Hot Topics of the Day|PHGKB


Last Posted: Apr 16, 2020

---

• Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing.
  Vlessis Katherine et al. JNCI cancer spectrum 2020 Feb 4(1) pkz095
• Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
  Torrorey-Sawe Rispah et al. Frontiers in genetics 2020 11170
• Population-based genetic testing for Women's cancer prevention.
  Evans Olivia et al. Best practice & research. Clinical obstetrics & gynaecology 2020 Mar
• I Have a BRCA1 Gene Mutation: The Extra Stress of COVID-19 Takes a Toll
  N McCoy, blog April 2, 2020
• Breast Conserving Surgery for BRCA Mutation Carriers-A Systematic Review.
  Co Michael et al. Clinical breast cancer 2019 Aug
• The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries.
  Laitman Yael et al. Human mutation 2019 40(11) e1-e23
• Prospective Evaluation of Universal BRCA Testing for Women With Triple-Negative Breast Cancer.
  Emborgo Trisha S et al. JNCI cancer spectrum 2020 Apr 4(2) pkaa002
• BRCA1 / BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies.
  Lee Anbok et al. Annals of laboratory medicine 2020 Mar 40(2) 114-121
• Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
  Riedlova P et al. Molecular biology reports 2020 Mar
• Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care.
  Hong Linda et al. Gynecologic and obstetric investigation 2020 Mar 1-8

more